(Q37027347)

17 August 2017

1 reference

title

Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering (English)

1 reference

17 August 2017

0 references

1 reference

1 reference

Kosmas I Paraskevas

1

1 reference

17 August 2017

publication date

8 December 2007

1 reference

International Urology and Nephrology

17 August 2017

published in

1 reference

17 August 2017

volume

40

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

165-170

1 reference

Comparative study of methyl-CpG-binding domain proteins

17 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11255-007-9307-6

Epidemiology of cardiovascular disease in chronic renal disease

21 January 2018

1 reference

12 December 2020

A placebo-controlled trial examining atorvastatin in dyslipidemic patients undergoing CAPD.

1 reference

12 December 2020

Statins and renal diseases: from primary prevention to renal replacement therapy

1 reference

12 December 2020

Undertreatment of hyperlipidemia in a cohort of United States kidney dialysis patients.

1 reference

12 December 2020

Lipid abnormalities in renal disease

1 reference

12 December 2020

Continuous ambulatory peritoneal dialysis in patients with renal failure due to multiple myeloma

1 reference

12 December 2020

Avoiding trouble down the line: the management and prevention of hemodialysis catheter-related infections

1 reference

12 December 2020

Inflammation in end-stage renal disease--a fire that burns within

1 reference

12 December 2020

Alternative strategies to evaluate the cost-effectiveness of peritoneal dialysis and hemodialysis.

1 reference

12 December 2020

Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study

1 reference

12 December 2020

Treatment with fluvastatin rapidly modulates, via different pathways, and in dependence on the baseline level, inflammation in hemodialysis patients

1 reference

12 December 2020

Hemodialysis versus continuous ambulatory peritoneal dialysis: effects on the heart

1 reference

12 December 2020

1 reference

12 December 2020

Peritoneal dialysis catheter placement: is laparoscopy an option?

1 reference

12 December 2020

HMG-CoA reductase inhibitors and the kidney

1 reference

12 December 2020

Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Underuse of American College of Cardiology/American Heart Association Guidelines in hemodialysis patients

1 reference

12 December 2020

Lipid and non-lipid effects of statins

1 reference

12 December 2020

Incidence and risk factors of coronary heart disease in elderly patients on chronic hemodialysis.

1 reference

12 December 2020

Morbidity and mortality of CAPD and hemodialysis.

1 reference

12 December 2020

USRDS: the United States Renal Data System

1 reference

12 December 2020

The pharmacokinetics of pravastatin in patients on chronic hemodialysis

1 reference

12 December 2020

Effects of atorvastatin on dyslipidaemia in uraemic patients on peritoneal dialysis

1 reference

12 December 2020

Statins: an essential component in the management of carotid artery disease

1 reference

12 December 2020

Pharmacokinetics of fluvastatin in subjects with renal impairment and nephrotic syndrome

1 reference

12 December 2020

Peritoneal dialysis infections recommendations

1 reference

12 December 2020

Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem.

1 reference

12 December 2020

Renal dysfunction does not alter the pharmacokinetics or LDL-cholesterol reduction of atorvastatin

1 reference

12 December 2020

Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering

1 reference

12 December 2020

Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients

1 reference

12 December 2020

Effect of short-term rosuvastatin treatment on estimated glomerular filtration rate

1 reference

12 December 2020

Prevention of membrane damage in patient on peritoneal dialysis with new peritoneal dialysis solutions

1 reference

12 December 2020

Clinical outcomes of elderly patients undergoing chronic peritoneal dialysis: experiences from one center and a review of the literature

1 reference

12 December 2020

Tuberculous lymphadenitis in patients undergoing continuous ambulatory peritoneal dialysis.

1 reference

12 December 2020

Over-the-counter statins

1 reference

12 December 2020

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

12 December 2020

Study of Heart and Renal Protection (SHARP)

1 reference

12 December 2020

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

12 December 2020

Peritoneal catheters and related infections

1 reference

12 December 2020

C-reactive protein (CRP)-lowering agents

1 reference

12 December 2020

Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure

1 reference

12 December 2020

HMG CoA reductase inhibitors (statins) for dialysis patients

1 reference

12 December 2020

Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures

1 reference

12 December 2020

Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis

1 reference

12 December 2020

Survival and morbidity of HIV patients on hemodialysis and peritoneal dialysis: one center's experience and review of the literature

1 reference

12 December 2020

Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study

1 reference

12 December 2020

Central venous catheter-related bacteremia in chronic hemodialysis patients: epidemiology and evidence-based management

1 reference

12 December 2020

Effects of statin therapy on the progression of chronic kidney disease

1 reference

12 December 2020

Atherogenic lipids and lipoproteins in hemodialysis patients

1 reference

12 December 2020

Residual renal function: considerations on its importance and preservation in dialysis patients

1 reference

12 December 2020

Management of dyslipidemias in patients with diabetes and chronic kidney disease

1 reference

12 December 2020

Comparison of peritoneal dialysis and haemodialysis after renal transplant failure.

1 reference

12 December 2020

Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality

1 reference

12 December 2020

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

12 December 2020

HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients

1 reference

12 December 2020

Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?

1 reference

12 December 2020

Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on high-sensitivity C-reactive protein levels

1 reference

12 December 2020

Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients

1 reference

12 December 2020

Does residual renal function decline more rapidly in hemodialysis than in peritoneal dialysis? How good is the evidence?

1 reference

12 December 2020

Causes of death in older peritoneal dialysis patients--can we depend on registry reports?

1 reference

12 December 2020

HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients

1 reference

12 December 2020

Non-lipid effects of statins: emerging new indications

1 reference

12 December 2020

Antimicrobial agents and catheter-related interventions to prevent peritonitis in peritoneal dialysis: Using evidence in the context of clinical practice

1 reference

12 December 2020

Quality of life of elderly patients undergoing continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Satisfaction of patients on chronic haemodialysis and peritoneal dialysis

1 reference

12 December 2020

The pleiotropic effects of statins.

1 reference

12 December 2020

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins).

1 reference

12 December 2020

Peritoneal dialysis in the patient with a failing renal allograft

1 reference

12 December 2020

Clinical benefits of slowing the progression of renal failure

1 reference

12 December 2020

Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis.

1 reference

12 December 2020

Prevention of infectious complications in peritoneal dialysis: best demonstrated practices

1 reference

12 December 2020

Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients

1 reference

12 December 2020

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and rhabdomyolysis: considerations in the renal failure patient

1 reference

12 December 2020

Efficacy, safety and tolerability of atorvastatin in dyslipidemic subjects with advanced (non-nephrotic) and endstage chronic renal failure

1 reference

12 December 2020

Simvastatin and fluvastatin reduce interleukin-6 and interleukin-8 lipopolysaccharide (LPS) stimulated production by isolated human monocytes from chronic kidney disease patients

1 reference

12 December 2020

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

1 reference

12 December 2020

Editorials: Are HMG‐CoA Reductase Inhibitors Underutilized in Dialysis Patients?

1 reference

12 December 2020

The impact of haemodialysis-associated variables on lipid profile in Egyptian haemodialysis population.

1 reference

12 December 2020

Quality of life in the elderly patients on dialysis

1 reference

12 December 2020

In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients

1 reference

12 December 2020

Statin Treatment and Diabetes Affect Myeloperoxidase Activity in Maintenance Hemodialysis Patients

1 reference

12 December 2020

10.1007/S11255-007-9307-6

Identifiers

DOI

1 reference

17 August 2017

1 reference